诚达药业
(301201)
| 流通市值：32.25亿 | | | 总市值：45.97亿 |
| 流通股本：1.09亿 | | | 总股本：1.55亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 818,598,607.96 | 445,496,148.82 | 178,463,170.9 | 479,133,966.54 |
| 交易性金融资产 | 281,962,591.33 | 645,132,195.37 | 957,652,020.32 | 704,965,066.7 |
| 应收票据及应收账款 | 117,590,978.27 | 129,852,780.29 | 94,969,047.08 | 73,246,021.66 |
| 其中：应收票据 | 2,446,006 | 20,774.75 | 291,272.04 | 1,688,200 |
| 应收账款 | 115,144,972.27 | 129,832,005.54 | 94,677,775.04 | 71,557,821.66 |
| 应收款项融资 | 0 | - | 1,771,823.96 | - |
| 预付款项 | 7,939,996.57 | 18,963,808.57 | 3,457,722.4 | 52,885,125.78 |
| 其他应收款合计 | 534,452.92 | 631,832.92 | 520,028.06 | 474,981.04 |
| 存货 | 153,010,511.73 | 127,034,089.95 | 135,271,478.91 | 128,366,651.49 |
| 合同资产 | 1,009,275.25 | 1,009,275.25 | 1,009,275.25 | - |
| 其他流动资产 | 38,563,326.35 | 41,037,037.18 | 42,049,089.26 | 24,131,899.34 |
| 流动资产合计 | 1,419,209,740.38 | 1,409,157,168.35 | 1,415,163,656.14 | 1,463,203,712.55 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 7,410,000 | 7,410,000 | 7,410,000 | 30,000,000 |
| 投资性房地产 | 45,969,691.35 | 46,255,384.92 | 46,541,078.49 | 46,826,772.06 |
| 固定资产 | 744,406,607.57 | 761,363,322.57 | 770,793,701.82 | 453,728,377.98 |
| 在建工程 | 79,824,494.04 | 66,164,257.16 | 101,455,413.56 | 253,210,454.71 |
| 无形资产 | 35,890,260.8 | 36,128,816.32 | 36,513,840.37 | 33,035,642.97 |
| 长期待摊费用 | 45,141,531.71 | 40,650,124.91 | 44,118,487.77 | 35,751,760.2 |
| 递延所得税资产 | 8,587,890.8 | 8,378,015.38 | 8,061,540.97 | 3,876,534.02 |
| 其他非流动资产 | 22,218,871.56 | 13,942,218.61 | 6,402,284.96 | 75,755,317.59 |
| 非流动资产合计 | 989,449,347.83 | 980,292,139.87 | 1,021,296,347.94 | 932,184,859.53 |
| 资产总计 | 2,408,659,088.21 | 2,389,449,308.22 | 2,436,460,004.08 | 2,395,388,572.08 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 143,981,231.1 | 138,345,655.74 | 189,227,095.01 | 146,386,538.8 |
| 其中：应付票据 | 11,605,156.36 | 15,244,841.2 | 23,265,564.2 | 22,925,615.7 |
| 应付账款 | 132,376,074.74 | 123,100,814.54 | 165,961,530.81 | 123,460,923.1 |
| 预收款项 | 251,863.02 | 110,106.12 | 16,283 | 101,570 |
| 合同负债 | 2,140,031.12 | 2,829,944.3 | 2,785,479.67 | 4,828,188.79 |
| 应付职工薪酬 | 4,648,573.43 | 7,133,602.78 | 5,032,448.89 | 1,133,000.58 |
| 应交税费 | 2,716,576.05 | 464,627.73 | 4,767,418.98 | 447,561.32 |
| 其他应付款合计 | 4,736,579.74 | 4,332,937.42 | 4,674,483.24 | 4,840,165.55 |
| 一年内到期的非流动负债 | 61,738.38 | - | 62,314.29 | - |
| 其他流动负债 | - | - | 194,136.62 | - |
| 流动负债合计 | 158,536,592.84 | 153,216,874.09 | 206,759,659.7 | 157,737,025.04 |
| 非流动负债: | | | | |
| 长期借款 | 88,197,679.9 | 88,197,679.9 | 80,118,379.9 | - |
| 递延收益 | 2,114,075.3 | 2,312,618.48 | 2,511,161.66 | 2,709,704.98 |
| 递延所得税负债 | 1,121,624.86 | 1,361,133.46 | 1,377,218.92 | 1,933,423.44 |
| 非流动负债合计 | 91,433,380.06 | 91,871,431.84 | 84,006,760.48 | 4,643,128.42 |
| 负债合计 | 249,969,972.9 | 245,088,305.93 | 290,766,420.18 | 162,380,153.46 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 154,713,824 | 154,713,824 | 154,713,824 | 154,713,824 |
| 资本公积 | 1,693,936,183.68 | 1,693,936,183.68 | 1,693,936,183.68 | 1,693,874,093.68 |
| 减:库存股 | 57,073,347.67 | 57,073,347.67 | 57,073,347.67 | 57,073,347.67 |
| 其他综合收益 | -19,201,500 | -19,201,500 | -19,201,500 | - |
| 盈余公积 | 58,491,579.28 | 58,491,579.28 | 58,491,579.28 | 55,907,973.27 |
| 未分配利润 | 325,008,542.44 | 310,784,184.13 | 312,184,166.11 | 383,264,221.12 |
| 归属于母公司股东权益合计 | 2,155,875,281.73 | 2,141,650,923.42 | 2,143,050,905.4 | 2,230,686,764.4 |
| 少数股东权益 | 2,813,833.58 | 2,710,078.87 | 2,642,678.5 | 2,321,654.22 |
| 股东权益合计 | 2,158,689,115.31 | 2,144,361,002.29 | 2,145,693,583.9 | 2,233,008,418.62 |
| 负债和股东权益合计 | 2,408,659,088.21 | 2,389,449,308.22 | 2,436,460,004.08 | 2,395,388,572.08 |
| 公告日期 | 2025-08-26 | 2025-04-25 | 2025-04-25 | 2024-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |